255 results on '"Ghaneh P"'
Search Results
2. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer
- Author
-
Raymant, Meirion, Astuti, Yuliana, Alvaro-Espinosa, Laura, Green, Daniel, Quaranta, Valeria, Bellomo, Gaia, Glenn, Mark, Chandran-Gorner, Vatshala, Palmer, Daniel H., Halloran, Christopher, Ghaneh, Paula, Henderson, Neil C., Morton, Jennifer P., Valiente, Manuel, Mielgo, Ainhoa, and Schmid, Michael C.
- Published
- 2024
- Full Text
- View/download PDF
3. Sonographic Assessment of Acute Versus Chronic Cholecystitis
- Author
-
Navarro, Shannon M, Chen, Shuai, Situ, Xiaolu, Corwin, Michael T, Loehfelm, Thomas, and Fananapazir, Ghaneh
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Digestive Diseases ,Adult ,Humans ,Gallbladder ,Sensitivity and Specificity ,Cholecystitis ,Cholecystitis ,Acute ,Ultrasonography ,Cholelithiasis ,Probability ,acute ,cholecystitis ,ultrasound ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
ObjectivesWhat sonographic variables are most predictive for acute cholecystitis? What variables differentiate acute and chronic cholecystitis?MethodsThe surgical pathology database was reviewed to identify adult patients who underwent cholecystectomy for cholecystitis and had a preceding ultrasound of the right upper quadrant within 7 days. A total of 236 patients were included in the study. A comprehensive imaging review was performed to assess for gallstones, gallbladder wall thickening, gallbladder distension, pericholecystic fluid, gallstone mobility, the sonographic Murphy's sign, mural hyperemia, and the common hepatic artery peak systolic velocity.ResultsOf 236 patients with a cholecystectomy, 119 had acute cholecystitis and 117 had chronic cholecystitis on surgical pathology. Statistical models were created for prediction. The simple model consists of three sonographic variables and has a sensitivity of 60% and specificity of 83% in predicting acute versus chronic cholecystitis. The most predictive variables for acute cholecystitis were elevated common hepatic artery peak systolic velocity, gallbladder distension, and gallbladder mural abnormalities. If a patient had all three of these findings on their preoperative ultrasound, the patient had a 96% chance of having acute cholecystitis. Two of these variables gave a 73-93% chance of having acute cholecystitis. One of the three variables gave a 40-76% chance of having acute cholecystitis. If the patient had 0 of 3 of the predictor variables, there was a 29% chance of having acute cholecystitis.ConclusionsGallbladder distension, gallbladder mural abnormalities, and elevated common hepatic artery peak systolic velocity are the most important sonographic variables in predicting acute versus chronic cholecystitis.
- Published
- 2023
4. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer
- Author
-
Meirion Raymant, Yuliana Astuti, Laura Alvaro-Espinosa, Daniel Green, Valeria Quaranta, Gaia Bellomo, Mark Glenn, Vatshala Chandran-Gorner, Daniel H. Palmer, Christopher Halloran, Paula Ghaneh, Neil C. Henderson, Jennifer P. Morton, Manuel Valiente, Ainhoa Mielgo, and Michael C. Schmid
- Subjects
Science - Abstract
Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease for which better therapies are urgently needed. Fibroblasts and macrophages are heterogeneous cell populations able to enhance metastasis, but the role of a macrophage-fibroblast crosstalk in regulating their pro-metastatic functions remains poorly understood. Here we deconvolve how macrophages regulate metastasis-associated fibroblast (MAF) heterogeneity in the liver. We identify three functionally distinct MAF populations, among which the generation of pro-metastatic and immunoregulatory myofibroblastic-MAFs (myMAFs) critically depends on macrophages. Mechanistically, myMAFs are induced through a STAT3-dependent mechanism driven by macrophage-derived progranulin and cancer cell-secreted leukaemia inhibitory factor (LIF). In a reciprocal manner, myMAF secreted osteopontin promotes an immunosuppressive macrophage phenotype resulting in the inhibition of cytotoxic T cell functions. Pharmacological blockade of STAT3 or myMAF-specific genetic depletion of STAT3 restores an anti-tumour immune response and reduces metastases. Our findings provide molecular insights into the complex macrophage–fibroblast interactions in tumours and reveal potential targets to inhibit PDAC liver metastasis.
- Published
- 2024
- Full Text
- View/download PDF
5. Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours
- Author
-
Patrick Freeman, Gaia Bellomo, Lucy Ireland, Maidinaimu Abudula, Teifion Luckett, Michael Oberst, Ruth Stafferton, Paula Ghaneh, Chris Halloran, Michael C. Schmid, and Ainhoa Mielgo
- Subjects
pancreatic cancer ,tumour microenvironment ,CD8+ T cell ,IGF ,macrophage ,fibroblast ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with an urgent unmet clinical need for new therapies. Using a combination of in vitro assays and in vivo preclinical models we demonstrate that therapeutic inhibition of the IGF signalling axis promotes the accumulation of CD8+ cytotoxic T cells within the tumour microenvironment of PDAC tumours. Mechanistically, we show that IGF blockade promotes macrophage and fibroblast production of the chemokines CXCL9 and CXCL10 to facilitate CD8+ T cell recruitment and trafficking towards the PDAC tumour. Exploring this pathway further, we show that IGF inhibition leads to increased STAT1 transcriptional activity, correlating with a downregulation of the AKT/STAT3 signalling axis, in turn promoting Cxcl9 and Cxcl10 gene transcription. Using patient derived tumour explants, we also demonstrate that our findings translate into the human setting. PDAC tumours are frequently described as “immunologically cold”, therefore bolstering CD8+ T cell recruitment to PDAC tumours through IGF inhibition may serve to improve the efficacy of immune checkpoint inhibitors which rely on the presence of CD8+ T cells in tumours.
- Published
- 2024
- Full Text
- View/download PDF
6. Variability in personal protective equipment in cross-sectional interventional abdominal radiology practices.
- Author
-
Planz, Virginia, Huang, Jennifer, Galgano, Samuel, Brook, Olga, and Fananapazir, Ghaneh
- Subjects
Biopsy ,Institutional practice ,Personal protective equipment ,COVID-19 ,Cross-Sectional Studies ,Humans ,Personal Protective Equipment ,Radiology ,Interventional ,SARS-CoV-2 - Abstract
PURPOSE: To determine institutional practice requirements for personal protective equipment (PPE) in cross-sectional interventional radiology (CSIR) procedures among a variety of radiology practices in the USA and Canada. METHODS: Members of the Society of Abdominal Radiology (SAR) CSIR Emerging Technology Commission (ETC) were sent an eight-question survey about what PPE they were required to use during common CSIR procedures: paracentesis, thoracentesis, thyroid fine needle aspiration (FNA), superficial lymph node biopsy, deep lymph node biopsy, solid organ biopsy, and ablation. Types of PPE evaluated were sterile gloves, surgical masks, gowns, surgical hats, eye shields, foot covers, and scrubs. RESULTS: 26/38 surveys were completed by respondents at 20/22 (91%) institutions. The most common PPE was sterile gloves, required by 20/20 (100%) institutions for every procedure. The second most common PPE was masks, required by 14/20 (70%) institutions for superficial and deep procedures and 12/12 (100%) institutions for ablation. Scrubs, sterile gowns, eye shields, and surgical hats were required at nearly all institutions for ablation, whereas approximately half of institutions required their use for deep lymph node and solid organ biopsy. Compared with other types of PPE, required mask and eye shield use showed the greatest increase during the SARS-CoV-2 pandemic. CONCLUSION: PPE use during common cross-sectional procedures is widely variable. Given the environmental and financial impact and lack of consensus practice, further studies examining the appropriate level of PPE are needed.
- Published
- 2022
7. Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach.
- Author
-
Cho, May T, Gholami, Sepideh, Gui, Dorina, Tejaswi, Sooraj L, Fananapazir, Ghaneh, Abi-Jaoudeh, Nadine, Jutric, Zeljka, Samarasena, Jason B, Li, Xiaodong, Valerin, Jennifer B, Mercer, Jacob, and Dayyani, Farshid
- Subjects
best practices ,biomarker testing ,challenges ,cholangiocarcinoma ,genomic alterations ,multidisciplinary ,next-generation sequencing ,precision medicine ,Digestive Diseases - (Gallbladder) ,Cancer ,Rare Diseases ,Liver Cancer ,Clinical Research ,Prevention ,Liver Disease ,Digestive Diseases ,Good Health and Well Being ,Oncology and Carcinogenesis - Abstract
Cholangiocarcinoma (CCA) is a heterogenous group of malignancies originating in the biliary tree, and associated with poor prognosis. Until recently, treatment options have been limited to surgical resection, liver-directed therapies, and chemotherapy. Identification of actionable genomic alterations with biomarker testing has revolutionized the treatment paradigm for these patients. However, several challenges exist to the seamless adoption of precision medicine in patients with CCA, relating to a lack of awareness of the importance of biomarker testing, hurdles in tissue acquisition, and ineffective collaboration among the multidisciplinary team (MDT). To identify gaps in standard practices and define best practices, multidisciplinary hepatobiliary teams from the University of California (UC) Davis and UC Irvine were convened; discussions of the meeting, including optimal approaches to tissue acquisition for diagnosis and biomarker testing, communication among academic and community healthcare teams, and physician education regarding biomarker testing, are summarized in this review.
- Published
- 2022
8. SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis
- Author
-
Hadi Sahrai, Ali Norouzi, Sina Hamzehzadeh, Alireza Majdi, Rana Kahfi-Ghaneh, and Saeed Sadigh-Eteghad
- Subjects
Alzheimer’s disease ,Mild cognitive impairment ,Serum ,Neurofilament light chain ,Single molecule array assays ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Abstract Background The single-molecule array assay (SIMOA)-based detection of neurofilament light (NFL) chain could be useful in diagnosing mild cognitive impairment (MCI) and Alzheimer’s disease (AD). This meta-analysis aimed to evaluate the circulating concentration of NFL in AD and MCI patients compared with healthy controls using the SIMOA technique. Methods To this end, Google Scholar, PubMed, Scopus, Web of Science, and the reference lists of relevant articles were systematically searched for studies reporting serum NFL chain levels in healthy controls, MCI, and AD patients. Appropriate statistical methods were employed to achieve the study purpose. Results Fifteen eligible studies including 3086 patients were pooled out of a total of 347 publications. Fixed effect model analysis showed that NFL chain level was significantly higher in the serum of patients with MCI (0.361 SMD, 95% CI, 0.286–0.435, p = 0.000, I 2 = 49.179) and AD (0.808 SMD, 95% CI, 0.727–0.888, p = 0.000, I 2 = 39.433) compared with healthy individuals. The analysis also showed that the NFL chain levels in plasma were significantly different between patients with MCI and AD (0.436 SMD, 95% CI, 0.359–0.513, p = 0.000, I 2 = 37.44). The overall heterogeneity of the studies was modest. Conclusions This study highlights the potential of serum NFL chain detected using SIMOA in differentiating MCI, AD, and healthy controls.
- Published
- 2023
- Full Text
- View/download PDF
9. Intra-ampullary papillary-tubular neoplasm
- Author
-
Sooraj Tejaswi, MD, MSPH, FASGE, Mili Parikh, MD, Ghaneh Fananapazir, MD, Kristin Olson, MD, and Dorina Gui, MD, PhD
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Published
- 2023
- Full Text
- View/download PDF
10. SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis
- Author
-
Sahrai, Hadi, Norouzi, Ali, Hamzehzadeh, Sina, Majdi, Alireza, Kahfi-Ghaneh, Rana, and Sadigh-Eteghad, Saeed
- Published
- 2023
- Full Text
- View/download PDF
11. Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging
- Author
-
Koh, Dow-Mu, Ba-Ssalamah, Ahmed, Brancatelli, Giuseppe, Fananapazir, Ghaneh, Fiel, M Isabel, Goshima, Satoshi, Ju, Sheng-Hong, Kartalis, Nikolaos, Kudo, Masatoshi, Lee, Jeong Min, Murakami, Takamichi, Seidensticker, Max, Sirlin, Claude B, Tan, Cher Heng, Wang, Jin, Yoon, Jeong Hee, Zeng, Mengsu, Zhou, Jian, and Taouli, Bachir
- Subjects
Rare Diseases ,Liver Disease ,Digestive Diseases ,Biomedical Imaging ,Chronic Liver Disease and Cirrhosis ,Cancer ,Liver Cancer ,Orphan Drug ,Oral and gastrointestinal ,Carcinoma ,Hepatocellular ,Consensus ,Contrast Media ,Gadolinium DTPA ,Humans ,Liver Neoplasms ,Magnetic Resonance Imaging ,Magnetic Resonance Spectroscopy ,Retrospective Studies ,Sensitivity and Specificity ,Gadoxetic acid ,Hepatocellular carcinoma ,Magnetic resonance imaging ,Metastatic liver disease ,Clinical Sciences ,Nuclear Medicine & Medical Imaging - Abstract
ObjectivesThe 9th International Forum for Liver Magnetic Resonance Imaging (MRI) was held in Singapore in September 2019, bringing together radiologists and allied specialists to discuss the latest developments in and formulate consensus statements for liver MRI, including the applications of gadoxetic acid-enhanced imaging.MethodsAs at previous Liver Forums, the meeting was held over 2 days. Presentations by the faculty on days 1 and 2 and breakout group discussions on day 1 were followed by delegate voting on consensus statements presented on day 2. Presentations and discussions centered on two main meeting themes relating to the use of gadoxetic acid-enhanced MRI in primary liver cancer and metastatic liver disease.Results and conclusionsGadoxetic acid-enhanced MRI offers the ability to monitor response to systemic therapy and to assist in pre-surgical/pre-interventional planning in liver metastases. In hepatocellular carcinoma, gadoxetic acid-enhanced MRI provides precise staging information for accurate treatment decision-making and follow-up post therapy. Gadoxetic acid-enhanced MRI also has potential, currently investigational, indications for the functional assessment of the liver and the biliary system. Additional voting sessions at the Liver Forum debated the role of multidisciplinary care in the management of patients with liver disease, evidence to support the use of abbreviated imaging protocols, and the importance of standardizing nomenclature in international guidelines in order to increase the sharing of scientific data and improve the communication between centers.Key points• Gadoxetic acid-enhanced MRI is the preferred imaging method for pre-surgical or pre-interventional planning for liver metastases after systemic therapy. • Gadoxetic acid-enhanced MRI provides accurate staging of HCC before and after treatment with locoregional/biologic therapies. • Abbreviated protocols for gadoxetic acid-enhanced MRI offer potential time and cost savings, but more evidence is necessary. The use of gadoxetic acid-enhanced MRI for the assessment of liver and biliary function is under active investigation.
- Published
- 2021
12. Clinical Importance of Incidentally Detected Hyperenhancing Liver Observations on Portal Venous Phase Computed Tomography in Patients Without Known Malignancy or Liver Disease
- Author
-
Corwin, Michael T, DiGeronimo, Ryan T, Navarro, Shannon M, Fananapazir, Ghaneh, Wilson, Machelle, and Loehfelm, Thomas W
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Liver Disease ,Digestive Diseases ,Rare Diseases ,Liver Cancer ,Clinical Research ,Chronic Liver Disease and Cirrhosis ,Biomedical Imaging ,Cancer ,Adult ,Aged ,Aged ,80 and over ,Female ,Follow-Up Studies ,Humans ,Incidental Findings ,Liver ,Liver Neoplasms ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Multimodal Imaging ,Portal Vein ,Retrospective Studies ,Tomography ,X-Ray Computed ,liver ,CT ,hyperenhancing ,hypervascular ,portal venous ,incidental ,Nuclear Medicine & Medical Imaging ,Clinical sciences ,Computer vision and multimedia computation - Abstract
ObjectiveThe aim of the study was to determine the prevalence of clinically important masses among incidental hyperenhancing liver observations on portal venous phase computed tomography (CT) in patients without known malignancy or liver disease.MethodsRetrospective search of portal venous phase CTs was performed to identify hyperenhancing liver observations in patients without cancer or liver disease. Observations were assigned a morphology of homogeneous, hemangioma, or heterogeneous. The reference standard was pathology (n = 2), liver protocol CT/magnetic resonance imaging (n = 40), follow-up portal venous phase CT for 2 years or more (n = 81), or clinical follow-up for 5 years or more (n = 107).ResultsThere were no clinically important masses among 83 observations with homogeneous morphology or 110 with hemangioma morphology. There were 2 clinically important masses (1 hepatocellular carcinoma and 1 hepatic adenoma) among 37 (5.4%) heterogeneous morphology observations.ConclusionsIncidental hyperenhancing liver observations on portal venous phase CT with homogeneous or typical hemangioma morphology in patients without known cancer or liver disease are highly likely benign.
- Published
- 2021
13. Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131 KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
- Author
-
Bosonnet Lorraine, Chauhan Seema, Lane Steven, Smith Catrin, Evans Jonathan E, Vinjamuri Sobhan, Raraty Michael GT, Shore Susannah, Sultana Asma, Garvey Conall, Sutton Robert, Neoptolemos John P, and Ghaneh Paula
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Advanced pancreatic cancer has a poor prognosis, and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage. However the drawback is the accompanying systemic toxicity, which targeted treatments may overcome. This study aimed to evaluate the safety and tolerability of KAb201, an anti-carcinoembryonic antigen monoclonal antibody, labelled with I131 in pancreatic cancer (ISRCTN 16857581). Methods Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas were randomised to receive KAb 201 via either the intra-arterial or intravenous delivery route. The dose limiting toxicities within each group were determined. Patients were assessed for safety and efficacy and followed up until death. Results Between February 2003 and July 2005, 25 patients were enrolled. Nineteen patients were randomised, 9 to the intravenous and 10 to the intra-arterial arms. In the intra-arterial arm, dose limiting toxicity was seen in 2/6 (33%) patients at 50 mCi whereas in the intravenous arm, dose limiting toxicity was noted in 1/6 patients at 50 mCi, but did not occur at 75 mCi (0/3). The overall response rate was 6% (1/18). Median overall survival was 5.2 months (95% confidence interval = 3.3 to 9 months), with no significant difference between the intravenous and intra-arterial arms (log rank test p = 0.79). One patient was still alive at the time of this analysis. Conclusion Dose limiting toxicity for KAb201 with I131 by the intra-arterial route was 50 mCi, while dose limiting toxicity was not reached in the intravenous arm.
- Published
- 2009
- Full Text
- View/download PDF
14. Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
- Author
-
Neoptolemos John P, Starling Naureen, Cunningham David, Ghaneh Paula, Sultana Asma, and Smith Catrin
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Recent meta-analyses have found a survival advantage with gemcitabine based combinations over single agent gemcitabine in patients with advanced pancreatic cancer. There is paucity of evidence in the form of direct head-to-head randomised controlled trials to determine which combinations are to be preferred. Method Using the adjusted indirect comparison method proposed by Bucher et al, we have assessed randomised controlled trials of four gemcitabine based combinations namely gemcitabine plus a platinum compound or 5-fluorouracil or irinotecan or capecitabine. Results No particular combination was significantly superior to another, but the indirect evidence suggests some important trends. Conclusion The strongest trends on indirect comparison are towards favouring gemcitabine plus capecitabine or gemcitabine plus a platinum compound over gemcitabine plus irinotecan, and to a lesser degree, over gemcitabine plus 5-fluorouracil.
- Published
- 2008
- Full Text
- View/download PDF
15. The Impact of Magnetic Resonance (MR) Exposure on the Menses
- Author
-
Klimkiv, Liliya, Fananapazir, Ghaneh, and Hou, Melody
- Abstract
Background: Magnetic resonance (MR) is a common imaging modality used in obstetrics and gynecology due its decreased radiation risk. MR risks specific to women have been studied, but mostly involve risks to a fetus in imaging done during pregnancy. In non-pregnant women, literature is limited to occupational survey evidence and case reports of abnormal uterine bleeding among female healthcare workers with frequent MR exposure and copper IUD use. Anecdotal reports from an online patient forum suggests a possible link with abnormal uterine bleeding after undergoing MR exposure. To our knowledge no formal research has been done to investigate abnormal uterine bleeding in association with MR exposure. This study aims to describe abnormal uterine bleeding, cramping/pelvic pain, or menstrual clotting after MR exposure in women who otherwise report regular menstrual cycles.
- Published
- 2021
16. Can the American Thyroid Association, K-Tirads, and Acr-Tirads Ultrasound Classification Systems Be Used to Predict Malignancy in Bethesda Category IV Nodules?
- Author
-
Yang, Wei, Fananapazir, Ghaneh, LaRoy, Jennifer, Wilson, Machelle, and Campbell, Michael J
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Cancer ,Biomedical Imaging ,Clinical Research ,Humans ,Retrospective Studies ,Thyroid Neoplasms ,Thyroid Nodule ,Ultrasonography ,United States ,Prevention ,ACR-TIRADS ,Bethesda Category 4 ,K-TIRADS ,Thyroid nodule ,ultrasound grading scheme ,Paediatrics and Reproductive Medicine ,Endocrinology & Metabolism ,Clinical sciences - Abstract
Objective: Management of thyroid nodules with Bethesda Category III and IV cytology on fine needle aspiration (FNA) is challenging as they cannot be adequately classified as benign or malignant. Ultrasound (US) patterns have demonstrated utility in evaluating the risk of malignancy (ROM) of Bethesda Category III nodules. This study aims to evaluate the value of three well established US grading systems (ATA, Korean-TIRADS, and ACR-TIRADS) in determining ROM in Bethesda Category IV nodules. Methods: 92 patients with 92 surgically resected thyroid nodules who had Bethesda Category IV cytology on FNA were identified. Nodule images were retrospectively graded using the three systems in a blinded manner. Associations between US risk category and malignant pathology for each system were analyzed. Results: Of the 92 nodules, 56 (61%) were benign and 36 (39%) were malignant. 47% of ATA high risk nodules, 53% of K-TIRADS category 5 nodules, and 50% of ACR-TIRADS category 5 nodules were malignant. The ATA high-risk category had 25% sensitivity, 82% specificity, 47% PPV for malignancy. K-TIRADS category 5 had 25% sensitivity, 85% specificity, 53% PPV for malignancy. ACR-TIRADS category 5 had 25% sensitivity, 84% specificity, 50% PPV for malignancy. None of the three grading systems yielded statistically significant correlation between US risk category and the ROM (p =0.30, 0.72, 0.28). Conclusion: The ATA, Korean-TIRADS, and ACR-TIRADS classification systems are not helpful in stratifying ROM in patients with Bethesda Category IV nodules. Clinicians should be cautious of using ultrasound alone when deciding between therapeutic options for patients with Bethesda Category IV thyroid nodules.
- Published
- 2020
17. Association of adipose tissue and skeletal muscle metrics with overall survival and postoperative complications in soft tissue sarcoma patients: an opportunistic study using computed tomography
- Author
-
Boutin, Robert D, Katz, Jeremy R, Chaudhari, Abhijit J, Yabes, Jonathan G, Hirschbein, Jonah S, Nakache, Yves-Paul, Seibert, J Anthony, Lamba, Ramit, Fananapazir, Ghaneh, Canter, Robert J, and Lenchik, Leon
- Subjects
Engineering ,Atomic ,Molecular and Optical Physics ,Physical Sciences ,Biomedical Engineering ,Bioengineering ,Biomedical Imaging ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,Cancer ,Computed tomography ,muscle ,myosteatosis ,sarcopenia ,soft-tissue sarcoma ,Condensed Matter Physics ,Optical Physics ,Other Physical Sciences ,Biomedical engineering ,Atomic ,molecular and optical physics - Abstract
BackgroundTo determine the relationship between adipose tissue and skeletal muscle measurements on computed tomography (CT) and overall survival and major postoperative complications in patients with soft-tissue sarcoma (STS).MethodsThe retrospective study included 137 STS patients (75 men, 62 women; mean age, 53 years, SD 17.7; mean BMI, 28.5, SD 6.6) who had abdominal CT exams. On a single CT image, at the L4 pedicle level, measurements of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), and skeletal muscle area and attenuation were obtained using clinical PACS and specialized segmentation software. Clinical information was recorded, including STS characteristics (size, depth, grade, stage, and site), overall survival, and postoperative complications. The relationships between CT metrics and survival were analyzed using Cox proportional hazard models and those between CT metrics and postoperative complications using logistic regression models.ResultsThere were 33 deaths and 41 major postoperative complications. Measured on clinical PACS, the psoas area (P=0.003), psoas index (P=0.006), psoas attenuation (P=0.011), and total muscle attenuation (P=0.023) were associated with overall survival. Using specialized software, psoas attenuation was also associated with overall survival (P=0.018). Adipose tissue metrics were not associated with survival or postoperative complications.ConclusionsIn STS patients, CT-derived muscle size and attenuation are associated with overall survival. These prognostic biomarkers can be obtained using specialized segmentation software or routine clinical PACS.
- Published
- 2020
18. Functional Adrenal Collision Tumor in a Patient with Cushing's Syndrome.
- Author
-
Zhou, Cathy, Fananapazir, Ghaneh, and Campbell, Michael J
- Subjects
Rare Diseases ,Cancer ,Nutrition ,Obesity ,Metabolic and endocrine - Abstract
Adrenal collision tumors are rare and produce unique diagnostic challenges for clinicians. We report the case of a 45-year-old woman with obesity and diabetes mellitus and an incidentally-discovered adrenal mass containing macroscopic fat, thought to be a myelolipoma. A functional workup confirmed adrenocorticotropic hormone- (ACTH-) independent Cushing's syndrome. The patient underwent a successful laparoscopic adrenalectomy with pathology showing an adrenal collision tumor consisting of an adrenocortical adenoma and a myelolipoma. Postoperatively, the clinical symptoms, body mass index, and hemoglobin A1C all improved. Clinicians should consider a functional workup in patients with radiographically diagnosed myelolipomas as some may prove to be hormonally active collision tumors.
- Published
- 2020
19. Incidentally Detected Focal Fundal Gallbladder Wall Thickening at Contrast-Enhanced Computed Tomography: Prevalence and Computed Tomography Features of Malignancy.
- Author
-
Corwin, Michael T, Khera, Satinderpal S, Loehfelm, Thomas W, Yang, Nuen Tsang, and Fananapazir, Ghaneh
- Subjects
Gallbladder ,Humans ,Gallbladder Neoplasms ,Contrast Media ,Diagnosis ,Differential ,Tomography ,X-Ray Computed ,Image Enhancement ,Radiographic Image Enhancement ,Incidental Findings ,Prevalence ,Retrospective Studies ,Middle Aged ,Female ,Male ,Biomedical Imaging ,adenomyomatosis ,focal wall thickening ,fundal ,gallbladder ,Clinical Sciences ,Nuclear Medicine & Medical Imaging - Abstract
ObjectiveThe aim of this study was to determine the prevalence and computed tomography (CT) features of malignancy in incidental focal fundal gallbladder wall thickening.MethodsPatients with incidental focal fundal gallbladder wall thickening on CT were included if they had an ultrasound or magnetic resonance imaging diagnostic of the etiology (n = 19), stability on CT for 1 year (n = 84), or pathological correlation (n = 13). Morphologies were classified as type 1 (nodular/pinched intramural low attenuation), type 2 (intramural low attenuation), type 3 (homogeneous enhancement), type 4 (nodular/pinched homogeneous enhancement), type 5 (intramural cystic spaces), or type 6 (hyperenhancing/heterogeneous enhancement).ResultsOne hundred sixteen patients had the following morphologies: type 1 (n = 57), type 2 (n = 10), type 3 (n = 6), type 4 (n = 19), type 5 (n = 14), and type 6 (n = 10). Four cases (3.4%; 95% confidence interval, 0.9%-8.6%) of malignancy were identified (type 6 in 3 and type 3 in 1).ConclusionsIncidental focal fundal gallbladder wall thickening is usually benign. Computed tomography features help distinguish benign from malignant etiologies.
- Published
- 2019
20. The Validity and Inter-Rater Reliability of a Video-Based Posture-Matching Tool to Estimate Cumulative Loads on the Lower Back
- Author
-
Saeed Ghaneh-Ezabadi, Mohammad Abdoli-Eramaki, Navid Arjmand, Alireza Abouhossein, and Seyed Abolfazl Zakerian
- Subjects
lifting ,cumulative spinal loads ,low back pain ,risk factors ,ergonomic assessment tool ,video analysis ,posture-matching ,validity ,inter-rater reliability ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Background: Low back pain (LBP) is known as one of the most common work-related musculoskeletal disorders. Spinal cumulative loads (CLs) during manual material handling (MMH) tasks are the main risk factors for LBP. However, there is no valid and reliable quantitative lifting analysis tool available for quantifying CLs among Iranian workers performing MMH tasks. Objective: This study aimed to investigate the validity and inter-rater reliability of a posture-matching load assessment tool (PLAT) for estimating the L5-S1 static cumulative compression (CC) and shear (CS) loads based on predictive regression equations.Material and Methods: This experimental study was conducted among six participants performing four lifting tasks, each comprised of five trials during which their posture was recorded via a motion capture (Vicon) and simultaneously a three-camera system located at three different angles (0°, 45°, and 90°) to the sagittal plane. Results: There were no significant differences between the two CLs estimated by PLAT from the three-camera system and the gold-standard Vicon. In addition, ten raters estimated CLs of the tasks using PLAT in three sessions. The calculated intra-class correlation coefficients for the estimated CLs within each task revealed excellent inter-rater reliability (> 0.75), except for CS in the first and third tasks, which were good (0.6 to 0.75). Conclusion: The proposed posture-matching approach provides a valid and reliable ergonomic assessment tool suitable for assessing spinal CLs during various lifting activities.
- Published
- 2022
- Full Text
- View/download PDF
21. Solutions of Einstein Field Equation for an Extra-Dimensional Anisotropic Metric with Two Scale Factors
- Author
-
Ghaneh, Taymaz
- Subjects
General Relativity and Quantum Cosmology - Abstract
The manuscript studies a 3+N+1-dimensional space in which the N extra dimensions are dynamically compact. The 3 large dimensions, behaving as the spacial part of the FRW metric, possess a different scale factor in comparison with the N extra ones, making the whole space anisotropic. The possible effects caused by the existence of a common time-like coordinate between the compact dimensions and our 3-dimensional hypersurface are investigated. The higher dimensional Friedmann-Like equations of the mentioned model are achieved. The continuity equation is reached at the special case of 3+4+1-dimensional metric. It is shown that not only the existence of the extra dimensions itself but also the pressure difference between the 3-dimensional hypersurface and the compact dimensions might get probed on the hypersurface as an additive source of gravity with the same behavior as baryonic matter. Furthermore, the relation between the coupling constant of the higher-dimensional universe and the Newton's constant of gravitation is investigated to reach an estimated limit for it. As another aim, the literature studies the role of dimensionality on the behavior of the higher-dimensional Friedmann equations., Comment: 9 pages
- Published
- 2017
22. Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication.
- Author
-
Corwin, Michael T, Lee, Andrew Y, Fananapazir, Ghaneh, Loehfelm, Thomas W, Sarkar, Souvik, and Sirlin, Claude B
- Subjects
Humans ,Carcinoma ,Hepatocellular ,Liver Neoplasms ,Tomography ,X-Ray Computed ,Risk Assessment ,Retrospective Studies ,Communication ,Radiology Information Systems ,Middle Aged ,Female ,Male ,Terminology as Topic ,Liver Imaging and Reporting Data System ,hepatocellular carcinoma ,radiology report ,terminology ,Cancer ,Liver Cancer ,Rare Diseases ,Liver Disease ,Digestive Diseases ,Biomedical Imaging ,Nuclear Medicine & Medical Imaging ,Clinical Sciences - Abstract
ObjectiveThe purpose of this study is to determine the correlation between malignancy risk of focal liver observations in patients at risk for hepatocellular carcinoma (HCC) implied by phrases used in nonstructured radiology reports with the risk inferred by hepatologists.Materials and methodsWe performed a retrospective review of nonstructured radiology reports issued before Liver Imaging and Reporting Data System (LI-RADS) adoption from four-phase liver CT examinations of patients at risk for HCC. The phrase used by the radiologist in the report impression to describe each focal liver observation was recorded. Five hepatologists independently inferred the LI-RADS category from each phrase. Two abdominal radiologists independently reviewed the images and, blinded to all other information, assigned a LI-RADS category to each observation. Discrepancies were resolved by consensus.ResultsOne hundred five observations in 77 patients were reported by 23 radiologists using 29 phrases. The most common phrase, "consistent with HCC" (n = 20), was applied to radiologist-assigned LR-3 (n = 1), LR-4 (n = 5), LR-5 (n = 11), and LR-5V (n = 3) observations. Eleven phrases were used more than once. Sixteen phrases were associated with LR-4 or higher observations; among these, hepatologists misinterpreted 37% of LR-4 or lower observations as definitely HCC and 46% of LR-5 and LR-5V observations as not definitely HCC. Overall, there was modest correlation (r = 0.69) between radiologist-assigned and hepatologist-inferred categories.ConclusionNonstandardized terminology results in inaccurate communication of HCC risk. Structured reporting systems such as LI-RADS may improve communication by conveying unambiguous estimates of malignancy risk.
- Published
- 2018
23. United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
- Author
-
Robert Van Der Meer, William Greenhalf, Eithne Costello, Daniel Palmer, William Reynolds, Paula Ghaneh, Robert Hanson, Tejpal Purewal, Richard J Jackson, Lucy Oldfield, Martyn Stott, Vatshala Chandran-Gorner, Laurence Alison, Ricardo Tejeiro, and Chris Halloran
- Subjects
Medicine - Abstract
Introduction Pancreatic cancer is a leading cause of cancer deaths worldwide. Screening for this disease has potential to improve survival. It is not feasible, with current screening modalities, to screen the asymptomatic adult population. However, screening of individuals in high-risk groups is recommended. Our study aims to provide resources and data that will inform strategies to screen individuals with new-onset diabetes (NOD) for pancreatic cancer.Methods and analysis The United Kingdom Early Detection Initiative (UK-EDI) for pancreatic cancer is a national, prospective, observational cohort study that aims to recruit 2500 individuals with NOD (
- Published
- 2022
- Full Text
- View/download PDF
24. A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy
- Author
-
Christopher M. Halloran, MD, John P. Neoptolemos, MD, Richard Jackson, PhD, Kellie Platt, MSc, Eftychia-Eirini Psarelli, MSc, Srikanth Reddy, PhD, Dhanwant Gomez, MD, Derek A. O’Reilly, PhD, Andrew Smith, MD, Thomas M. Pausch, MD, Andreas Prachalias, MD, Brian Davidson, MD, and Paula Ghaneh, MD
- Subjects
Surgery ,RD1-811 - Abstract
Objective:. Whether a Blumgart anastomosis (BA) is superior to Cattell-Warren anastomosis (CWA) in terms of postoperative pancreatic fistula (POPF) following pancreatoduodenectomy. Importance:. Complications driven by POPF following pancreatic cancer resection may hinder adjuvant therapy, shortening survival. BA may reduce complications compared to CWA, improving the use of adjuvant therapy and prolonging survival. Methods:. A multicenter double-blind, controlled trial of patients undergoing resection for suspected pancreatic head cancer, randomized during surgery to a BA or CWA, stratified by pancreatic consistency and duct diameter. The primary end point was POPF, and secondary outcome measures were adjuvant therapy use, specified surgical complications, quality of life, and survival from the date of randomization. For a 10% POPF reduction, 416 patients were required, 208 per arm (two-sided α = 0·05; power = 80%). Results:. Z-score at planned interim analysis was 0.474 so recruitment was held to 238 patients; 236 patients were analyzed (112 BA and 124 CWA). No significant differences in POPF were observed between BA and CWA, odds ratio (95% confidence interval [CI]) 1·04 (0.58–1.88), P = 0.887, nor in serious adverse events. Adjuvant therapy was delivered to 98 (62%) of 159 eligible patients with any malignancy; statistically unrelated to arm or postoperative complications. Twelve-month overall survival, hazard ratio (95% CI), did not differ between anastomoses; BA 0.787 (0.713–0.868) and CWA 0.854 (0.792–0.921), P = 0.266, nor for the 58 patients with complications, median (IQR), 0.83 (0.74–0.91) compared to 101 patients without complications 0.82 (0.76–0.89) (P = 0.977). Conclusions:. PANasta represents the most robust analysis of BA versus CWA to date.
- Published
- 2022
- Full Text
- View/download PDF
25. The Impact of Employment Status and Occupation Type on Occupational Stress and General Health of Physically Disabled Employees in Vocational Centers of the State Welfare Organization of Tehran: A Cross-Sectional Study
- Author
-
Seyed Abolfazl Zakerian, Maral Saadat, Saeed Ghaneh-Ezabadi, Leila Nezamabadi-Farahani, and Kianoush Abdi
- Subjects
physically disabled ,employment status ,occupation type ,general health ,occupational stress ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Objective: Disabled people experience worse situation in respect of the stress, health, and socio-demographic indicators than healthy people. Little knowledge is available about the way in which this disadvantage is patterned by employment status and occupation type, especially in employees with physical disabilities. Few studies have investigated the potential effect of employment status and occupation type on general health and occupational stress in physically disabled employees. This study investigated the role of employment status and occupation type and demographic factors in predicting general health and also, examined the relations between occupational stress and general health while adjusting for demographic factors among employees with physical disabilities in vocational centers of the State Welfare Organization in Tehran City, Iran. Materials & Methods: This was a descriptive-analytical study with a cross-sectional design. The study was performed among 273 people with physical disabilities employed in the productive workrooms of vocational rehabilitation centers of Tehran, which were selected via convenience sampling. Data collection tools were Occupational Stress Index (OSI) developed by Belkic (1991) based upon cognitive ergonomics concept to measure the five key potential work-related stressors, Goldberg’s 28-item General Health Questionnaires (GHQ-28) (1979) to detect psychiatric illness as well as current psychological state in the past month and self-administered demographic form. Data analysis was conducted in SPSS software, using the independent t-test, one-way ANOVA and multiple linear regression. Results: The Mean±SD age of the physically disabled employees was 33.65 (3.76) years. Most of them were aged 30 to 39 years. (55.2%), men (60.4%), married (60.4%), with part-time employment (67%) and engaged in productive affairs (30%). The relationship between general health and occupational stress with gender and marital status was found to be significant (P
- Published
- 2021
- Full Text
- View/download PDF
26. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial
- Author
-
Brian R Davidson, Elena Pizzo, Veronica Ranieri, Kurinchi Gurusamy, Eftychia Eirini Psarelli, Derek Manas, Peter Littler, Daniel H Palmer, Nicola de Liguori Carino, Zainab L Rai, Pauleh Ghaneh, Roopinder Gilmore, Praveen Peddu, and David C Bartlett
- Subjects
Medicine - Abstract
Background Approximately 30% of patients with pancreas cancer have unresectable locally advanced disease, which is currently treated with systemic chemotherapy. A new treatment option of irreversible electroporation (IRE) has been investigated for these patients since 2005. Cohort studies suggest that IRE confers a survival advantage, but with associated, procedure-related complications. Selection bias may account for improved survival and there have been no prospective randomised trials evaluating the harms and benefits of therapy. The aim of this trial is to evaluate the feasibility of a randomised comparison of IRE therapy with chemotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer (LAPC).Methods and analysis Eligible patients with LAPC who have undergone first-line 5-FluoroUracil, Leucovorin, Irinotecan and Oxaliplatin chemotherapy will be randomised to receive either a single session of IRE followed by (if indicated) further chemotherapy or to chemotherapy alone (standard of care). Fifty patients from up to seven specialist pancreas centres in the UK will be recruited over a period of 15 months. Trial follow-up will be 12 months. The primary outcome measure is ability to recruit. Secondary objectives include practicality and technical success of treatment, acceptability of treatment to patients and clinicians and safety of treatment. A qualitative study has been incorporated to evaluate the patient and clinician perspective of the locally advanced pancreatic cancer with percutaneous irreversible electroporation trial. It is likely that the data obtained will guide the structure, the primary outcome measure, the power and the duration of a subsequent multicentre randomised controlled trial aimed at establishing the clinical efficiency of pancreas IRE therapy. Indicative procedure-related costings will be collected in this feasibility trial, which will inform the cost evaluation in the subsequent study on efficiency.Ethics and dissemination The protocol has received approval by London-Brent Research Ethics Committee reference number 21/LO/0077.Results will be analysed following completion of trial recruitment and follow-up. Results will be presented to international conferences with an interest in oncology, hepatopancreaticobiliary surgery and interventional radiology and be published in a peer-reviewed journal.Trial registration number ISRCTN14986389.
- Published
- 2022
- Full Text
- View/download PDF
27. Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial
- Author
-
Yukiyasu Okamura, Narikazu Boku, Paula Ghaneh, William Greenhalf, Satoru Yasukawa, Hiroto Narimatsu, Akira Fukutomi, Masaru Konishi, Soichiro Morinaga, Hirochika Toyama, Atsuyuki Maeda, Yasuhiro Shimizu, Shoji Nakamori, Naohiro Sata, Keisuke Yamakita, Amane Takahashi, Wataru Takayama, Ryuzo Yamaguchi, Moriaki Tomikawa, Akio Yanagisawa, John P. Neoptolemos, and Katsuhiko Uesaka
- Subjects
10D7G2 ,gemcitabine ,human equilibrative nucleoside transporter‐1 ,pancreatic cancer ,SP120 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Expression of human equilibrative nucleoside transporter‐1 (hENT1) is reported to predict survival of gemcitabine (GEM)‐treated patients. However, predictive values of immunohistochemical hENT1 expression may differ according to the antibodies, 10D7G2 and SP120. Aim We aimed to investigate the concordance of immunohistochemical hENT1 expression between the two antibodies and prognosis. Methods The subjects of this study were totally 332 whose formalin‐fixed paraffin‐embedded specimens and/or unstained sections were obtained. The individual H‐scores and four classifications according to the staining intensity were applied for the evaluation of hENT1 expression by 10D7G2 and SP120, respectively. Results The highest concordance rate (79.8%) was obtained when the cut‐off between high and low hENT1 expression using SP120 was set between moderate and strong. There were no correlations of hENT1 mRNA level with H‐score (p = .258). Although the hENT1 mRNA level was significantly different among four classifications using SP120 (p = .011), there was no linear relationship among them. Multivariate analyses showed that adjuvant GEM was a significant predictor of the patients with low hENT1 expression using either 10D7G2 (Hazard ratio [HR] 2.39, p = .001) or SP120 (HR 1.84, p
- Published
- 2022
- Full Text
- View/download PDF
28. Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP
- Author
-
Mukherjee, Rajarshi, Mareninova, Olga A, Odinokova, Irina V, Huang, Wei, Murphy, John, Chvanov, Michael, Javed, Muhammad A, Wen, Li, Booth, David M, Cane, Matthew C, Awais, Muhammad, Gavillet, Bruno, Pruss, Rebecca M, Schaller, Sophie, Molkentin, Jeffery D, Tepikin, Alexei V, Petersen, Ole H, Pandol, Stephen J, Gukovsky, Ilya, Criddle, David N, Gukovskaya, Anna S, Sutton, Robert, Latawiec, Diane, Rajamanoharan, Dayani, Mclaughlin, Euan, Ghaneh, Paula, Halloran, Christopher, Neoptolemos, John P, Raraty, Michael GT, and French, Samuel W
- Subjects
Digestive Diseases ,Prevention ,5.1 Pharmaceuticals ,Aetiology ,2.1 Biological and endogenous factors ,Development of treatments and therapeutic interventions ,Oral and gastrointestinal ,Acinar Cells ,Animals ,Autophagy ,Calcium ,Cell Culture Techniques ,Disease Models ,Animal ,Humans ,Inositol Phosphates ,Mice ,Mitochondria ,Mitochondrial Membrane Transport Proteins ,Mitochondrial Permeability Transition Pore ,Mitochondrial Proteins ,Necrosis ,Pancreas ,Pancreatitis ,Acute Necrotizing ,Phosphoprotein Phosphatases ,NIHR Pancreas Biomedical Research Unit ,ACUTE PANCREATITIS ,CELL DEATH ,CELL SIGNALLING ,Clinical Sciences ,Paediatrics and Reproductive Medicine ,Gastroenterology & Hepatology - Abstract
ObjectiveAcute pancreatitis is caused by toxins that induce acinar cell calcium overload, zymogen activation, cytokine release and cell death, yet is without specific drug therapy. Mitochondrial dysfunction has been implicated but the mechanism not established.DesignWe investigated the mechanism of induction and consequences of the mitochondrial permeability transition pore (MPTP) in the pancreas using cell biological methods including confocal microscopy, patch clamp technology and multiple clinically representative disease models. Effects of genetic and pharmacological inhibition of the MPTP were examined in isolated murine and human pancreatic acinar cells, and in hyperstimulation, bile acid, alcoholic and choline-deficient, ethionine-supplemented acute pancreatitis.ResultsMPTP opening was mediated by toxin-induced inositol trisphosphate and ryanodine receptor calcium channel release, and resulted in diminished ATP production, leading to impaired calcium clearance, defective autophagy, zymogen activation, cytokine production, phosphoglycerate mutase 5 activation and necrosis, which was prevented by intracellular ATP supplementation. When MPTP opening was inhibited genetically or pharmacologically, all biochemical, immunological and histopathological responses of acute pancreatitis in all four models were reduced or abolished.ConclusionsThis work demonstrates the mechanism and consequences of MPTP opening to be fundamental to multiple forms of acute pancreatitis and validates the MPTP as a drug target for this disease.
- Published
- 2016
29. JOURNAL CLUB: Quantification of Fetal Dose Reduction if Abdominal CT Is Limited to the Top of the Iliac Crests in Pregnant Patients With Trauma.
- Author
-
Corwin, Michael T, Seibert, J Anthony, Fananapazir, Ghaneh, Lamba, Ramit, and Boone, John M
- Subjects
Reproductive Medicine ,Biomedical and Clinical Sciences ,Clinical Sciences ,Conditions Affecting the Embryonic and Fetal Periods ,Physical Injury - Accidents and Adverse Effects ,Pediatric ,Clinical Research ,Reproductive health and childbirth ,Abdominal Injuries ,Adolescent ,Adult ,Contrast Media ,Female ,Fetus ,Gestational Age ,Humans ,Ilium ,Pelvis ,Pregnancy ,Radiation Protection ,Radiographic Image Interpretation ,Computer-Assisted ,Retrospective Studies ,CT ,fetal dose ,pregnant ,radiation dose ,trauma ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
ObjectiveThe purposes of this study were to correlate fetal z-axis location within the maternal abdomen on CT with gestational age and estimate fetal dose reduction of a study limited to the abdomen only, with its lower aspect at the top of the iliac crests, compared with full abdominopelvic CT in pregnant trauma patients.Materials and methodsWe performed a study of pregnant patients who underwent CT of the abdomen and pelvis for trauma at a single institution over a 10-year period. The inferior aspect of maternal liver, spleen, gallbladder, pancreas, adrenals, and kidneys was recorded as above or below the iliac crests. The distance from the iliac crest to the top of the fetus or gestational sac was determined. The CT images of the limited and full scanning studies were independently reviewed by two blinded radiologists to identify traumatic injuries. Fetal dose profiles, including both scatter and primary radiation, were computed analytically along the central axis of the patient to estimate fetal dose reduction. Linear regression analysis was performed between gestational age and distance of the fetus to the iliac crests.ResultsThirty-five patients were included (mean age, 26.2 years). Gestational age ranged from 5 to 38 weeks, with 5, 19, and 11 gestations in the first, second, and third trimesters, respectively. All solid organs were above the iliac crests in all patients. In three of six patients, traumatic findings in the pelvis would have been missed with the limited study. There was high correlation between gestational age and distance of the fetus to the iliac crests (R(2) = 0.84). The mean gestational age at which the top of the fetus was at the iliac crest was 17.3 weeks. Using the limited scanning study, fetuses at 5, 20, and 40 weeks of gestation would receive an estimated 4.3%, 26.2%, and 59.9% of the dose, respectively, compared with the dose for the full scanning study.ConclusionIn pregnant patients in our series with a history of trauma, CT of the abdomen only was an effective technique to reduce fetal radiation exposure compared with full abdomen and pelvis CT.
- Published
- 2016
30. MR Angiography of Renal Transplant Vasculature with Ferumoxytol: Comparison of High-Resolution Steady-State and First-Pass Acquisitions
- Author
-
Corwin, Michael T, Fananapazir, Ghaneh, and Chaudhari, Abhijit J
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biomedical Imaging ,Transplantation ,Kidney Disease ,Adult ,Algorithms ,Contrast Media ,Female ,Ferrosoferric Oxide ,Humans ,Iliac Artery ,Image Enhancement ,Image Processing ,Computer-Assisted ,Imaging ,Three-Dimensional ,Kidney ,Kidney Transplantation ,Magnetic Resonance Angiography ,Male ,Middle Aged ,Radiography ,Retrospective Studies ,Signal-To-Noise Ratio ,Steady state ,MRA ,ferumoxytol ,renal transplant ,nephrotoxicity ,contrast ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
Rationale and objectivesThis work aimed to quantify the differences in signal-to-noise ratio (SNR) and vessel sharpness between steady-state and first-pass magnetic resonance angiography (MRA) with ferumoxytol in renal transplant recipients.Materials and methodsWe performed a retrospective study of adult patients who underwent steady-state and first-pass MRA with ferumoxytol to evaluate renal transplant vasculature. SNR was calculated in the external iliac artery, and vessel sharpness was calculated in the external iliac and renal transplant arteries for both acquisitions. Data were compared using Student's t test.ResultsFifteen patients were included (mean age 56.9 years, 10 males). The mean SNR of the external iliac artery was 42.2 (SD, 11.9) for the first-pass MRA and 41.8 (SD, 9.7) for the steady-state MRA (p = 0.92). The mean vessel sharpness was significantly higher for the steady-state MRA compared to first-pass MRA for both external iliac (1.24 vs. 0.80 mm(-1), p
- Published
- 2016
31. Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes
- Author
-
Lucy Oldfield, Anthony Evans, Rohith Gopala Rao, Claire Jenkinson, Tejpal Purewal, Eftychia E. Psarelli, Usha Menon, John F. Timms, Stephen P. Pereira, Paula Ghaneh, William Greenhalf, Christopher Halloran, and Eithne Costello
- Subjects
Pancreatic cancer ,Early detection ,Type 3c diabetes ,Blood biomarkers ,Adiponectin ,IL-1Ra ,Medicine ,Medicine (General) ,R5-920 - Abstract
Summary: Background: Screening for pancreatic ductal adenocarcinoma (PDAC) in populations at high risk is recommended. Individuals with new-onset type 2 diabetes mellitus (NOD) are the largest high-risk group for PDAC. To facilitate screening, we sought biomarkers capable of stratifying NOD subjects into those with type 2 diabetes mellitus (T2DM) and those with the less prevalent PDAC-related diabetes (PDAC-DM), a form of type 3c DM commonly misdiagnosed as T2DM. Methods: Using mass spectrometry- and immunoassay-based methodologies in a multi-stage analysis of independent sample sets (n=443 samples), blood levels of 264 proteins were considered using Ingenuity Pathway Analysis, literature review and targeted training and validation. Findings: Of 30 candidate biomarkers evaluated in up to four independent patient sets, 12 showed statistically significant differences in levels between PDAC-DM and T2DM. The combination of adiponectin and interleukin-1 receptor antagonist (IL-1Ra) showed strong diagnostic potential, (AUC of 0.91; 95% CI: 0.84-0.99) for the distinction of T3cDM from T2DM. Interpretation: Adiponectin and IL-1Ra warrant further consideration for use in screening for PDAC in individuals newly-diagnosed with T2DM. Funding: North West Cancer Research, UK, Cancer Research UK, Pancreatic Cancer Action, UK.
- Published
- 2022
- Full Text
- View/download PDF
32. Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position
- Author
-
Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., and Mukherjee, Somnath
- Published
- 2020
- Full Text
- View/download PDF
33. Signature Change by GUP
- Author
-
Ghaneh, T., Darabi, F., and Motavalli, H.
- Subjects
General Relativity and Quantum Cosmology - Abstract
We revisit the issue of continuous signature transition from Euclidean to Lorentzian metrics in a cosmological model described by FRW metric minimally coupled with a self interacting massive scalar field. Then, using a noncommutative phase space of dynamical variables deformed by Generalized Uncertainty Principle (GUP) we show that the signature transition occurs even for a model described by FRW metric minimally coupled with a free massless scalar field accompanied by a cosmological constant. This indicates that the continuous signature transition might have been easily occurred at early universe just by a free massless scalar field, a cosmological constant and a noncommutative phase space deformed by GUP, without resorting to a massive scalar field having an {\it ad hoc} complicate potential. We also study the quantum cosmology of the model and obtain a solution of Wheeler-DeWitt equation which shows a good correspondence with the classical path., Comment: 14 pages, to be published in IJMPD
- Published
- 2012
- Full Text
- View/download PDF
34. Signature Change in Noncommutative FRW Cosmology
- Author
-
Ghaneh, Taymaz, Darabi, Farhad, and Motavalli, Hossein
- Subjects
General Relativity and Quantum Cosmology ,83F05 - Abstract
The conditions for which the no boundary proposal may have a classical realization of a continuous change of signature, are investigated for a cosmological model described by FRW metric coupled with a self interacting scalar field, having a noncommutative phase space of dynamical variables. The model is then quantized and a good correspondence is shown between the classical and quantum cosmology indicating that the noncommutativity does not destruct the classical-quantum correspondence. It is also shown that the quantum cosmology supports a signature transition where the bare cosmological constant takes a vast continuous spectrum of negative values. The bounds of bare cosmological constant are limited by the values of noncommutative parameters. Moreover, it turns out that the physical parameters are constrained by the noncommutativity parametres., Comment: 15 pages, 4 figures, Minor revision, references added
- Published
- 2012
- Full Text
- View/download PDF
35. The prevalence of musculoskeletal discomforts and its relation with work posture in Carpet Weavers, Boshruyeh City
- Author
-
Mojtaba Mokhtari, Gholam Hossein Halvani, Zohreh Rahayi, Hossein Fallah, Saeed Ghaneh, and Farimah Shamsi
- Subjects
cmdq ,ocra ,musculoskeletal discomfort ,posture assessment ,carpet weaver ,Special situations and conditions ,RC952-1245 - Abstract
Introduction: Carpet industry is one of the most important, dangerous and traditional industries in Iran. Non-Ergonomic factors such as non-standard work tools, inappropriate physical postures, long hours of work and insufficient rest of carpet weavers can lead to musculoskeletal disorders. The purpose of this study was to determine the prevalence of musculoskeletal discomfort and its relationship with posture in rural carpet weavers in Boshruyeh city. Methods: This study is descriptive, analytical and cross-sectional. The sampling method was census-based and included all rural carpet weavers in Boshruyeh city who were active at least 6 months prior to the beginning of the study and were willing to cooperate (62 people). In order to investigate musculoskeletal discomforts, used from Cornell Musculoskeletal Discomfort Questionnaire (CMDQ) and for posture assessment, The Occupational Repetitive Action Index (OCRA) method was used. The collected data by using SPSS software IBM 24 (Pearson correlation test) was analyzed. Results: The results showed that 98.39% of the workers felt discomfort at least in one of the 20 assessed regions. The most common discomfort of carpet weavers was 72.88% in the lower back region and the lowest incidence of discomfort was 9.68% in the hip/buttocks. There was a significant statistical relationship between scores of musculoskeletal discomforts in 11of 20 assessed regions with OCRA score (p
- Published
- 2019
36. Cost Analysis and Outcomes of Endoscopic, Minimal Access and Open Pancreatic Necrosectomy
- Author
-
Rebecca Saunders, MBChB, Faye E. Hughes, BSc, Jonathan C. Evans, MRCP, FRCR, Howard L. Smart, DM, FRCP, Paula Ghaneh, MD, FRCS, Jayapal Ramesh, FRCR, Robert Sutton, DPhil, FRCS, and Christopher M. Halloran, BSc, MD, FRCS, SFHEA
- Subjects
Surgery ,RD1-811 - Abstract
Objectives:. To assess both individual patient and institutional costs as well as outcomes in patients with pancreatic necrosis who underwent either endoscopic, minimal access or open pancreatic necrosectomy. These data can be used to evaluate clinical effectiveness with a view to informing local healthcare providers. Background:. Intervention for infected pancreatic necrosis is associated with a high morbidity, mortality, and long hospital stays. Minimal access surgical step-up approaches have been the gold standard of care; however, endoscopic approaches are now offered preferentially. Methods:. All patients undergoing endoscopic (EN), minimal access retroperitoneal (MARPN), and open (OPN) necrosectomy at a single institution from April 2015 to March 2017 were included. Patients were selected for intervention based on morphology and position of the necrosis and on clinical factors. Patient-level costing systems were used to determine inpatient and outpatient costs. Results:. Eighty-six patients were included: 38 underwent EN, 35 MARPN, and 13 OPN. Preoperative APACHEII was 6 versus 9 versus 9 (P = 0.017) and CRP 107 versus 204 versus 278 (P = 0.012), respectively. Postoperative stay was 19 days for EN versus 41 for MARPN versus 42 for OPN (P = 0.007). Complications occurred in 68.4%, 68.6%, and 46.2% (P = 0.298), whereas mortality was 10.5%, 22.9%, and 15.4% (P = 0.379), respectively. Mean total cost was £31,364 for EN, £52,770 for MARPN (P = 0.008), and £60,346 for OPN. Ward and critical care costs for EN were lower than for MARPN (ward: £9430 vs £14,033, P = 0.024; critical care: £5317 vs £16,648, P = 0.056). Conclusions:. EN was at least as safe and effective as MARPN and OPN and was associated with markedly reduced hospital stay and cost, although some markers of disease severity were higher in patients undergoing MARPN and OPN. These results support EN as the preferred approach to necrosectomy, but hybrid utilization of all available techniques remains integral to optimal outcomes.
- Published
- 2021
- Full Text
- View/download PDF
37. Single-Port Retroperitoneal Pancreatic Necrosectomy for the Treatment of Extrapancreatic Walled-Off Necrotic Collections
- Author
-
Rebecca Saunders, MBChB, MRCS, John P. Neoptolemos, MD, FRCS, FMedSci, Faye Hughes, BSc, MSc, Paula Ghaneh, MD, FRCS, and Christopher M. Halloran, BSc, MD, FRCS
- Subjects
Surgery ,RD1-811 - Published
- 2021
- Full Text
- View/download PDF
38. Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach
- Author
-
Radhakrishna, Ganesh and Ghaneh, Paula
- Published
- 2021
- Full Text
- View/download PDF
39. The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis
- Author
-
Sheel, A. R. G., Baron, R. D., Dickerson, L. D., Ghaneh, P., Campbell, F., Raraty, M. G. T., Yip, V., Halloran, C. M., and Neoptolemos, J. P.
- Published
- 2019
- Full Text
- View/download PDF
40. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma
- Author
-
Mann, Kulbir, Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., Halloran, C., Neoptolemos, J., and Ghaneh, P.
- Published
- 2019
- Full Text
- View/download PDF
41. Functional Adrenal Collision Tumor in a Patient with Cushing’s Syndrome
- Author
-
Cathy Zhou, Ghaneh Fananapazir, and Michael J. Campbell
- Subjects
Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Adrenal collision tumors are rare and produce unique diagnostic challenges for clinicians. We report the case of a 45-year-old woman with obesity and diabetes mellitus and an incidentally-discovered adrenal mass containing macroscopic fat, thought to be a myelolipoma. A functional workup confirmed adrenocorticotropic hormone- (ACTH-) independent Cushing’s syndrome. The patient underwent a successful laparoscopic adrenalectomy with pathology showing an adrenal collision tumor consisting of an adrenocortical adenoma and a myelolipoma. Postoperatively, the clinical symptoms, body mass index, and hemoglobin A1C all improved. Clinicians should consider a functional workup in patients with radiographically diagnosed myelolipomas as some may prove to be hormonally active collision tumors.
- Published
- 2020
- Full Text
- View/download PDF
42. Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”
- Author
-
Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., and Mukherjee, Somnath
- Published
- 2021
- Full Text
- View/download PDF
43. Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
- Author
-
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, A., Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W., and for the European Study Group for Pancreatic Cancer
- Published
- 2018
- Full Text
- View/download PDF
44. Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
- Author
-
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G, Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, Alan, Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W., and for the European Study Group for Pancreatic Cancer
- Published
- 2018
- Full Text
- View/download PDF
45. Disability and Self-Care among Elders in Yazd
- Author
-
Batool Ghaneh, Seyed Houssein Saeed- Banadaky, Zohreh Rahaei, Hassan Rezaeipandari, and Ehsan Mohiti Ardakani
- Subjects
Disability ,Self-care ,Elders ,Geriatrics ,RC952-954.6 - Abstract
Introduction: Geriatric syndromes lead to a number of disabilities which dramatically affect the quality of life in ageing. Facilitating the process of self-care can improve the elder's health to a great extent which has received less attention in previous studies. This study aimed at investigating the relationship between the disability and self-care in the elderly of Yazd. Methods: This cross-sectional study was conducted in Yazd; 234 elderly participants were selected through cluster random sampling. WHODAS-II questionnaire and a researcher-designed self-care questionnaire were utilized and collected data analyzed using Mann-Whitney U, Kruskal-Wallis H, chi-square and Spearman correlation coefficient tests. Results: The mean score of disability was 38.55 ±13.71 (ranging from 0 to 92) and the mean score of self-care was 61.57± 15.94 (ranging from 0 to 118). There was no statistically significant correlation between total score of disability and self-care, however, correlation was detected between the subscales. Conclusion: Given the high level of disability in a majority of elders and low level of their self-care, self-care promotion programs and prevention of disabilities in collaboration with their families and health centers are recommended.
- Published
- 2016
46. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial
- Author
-
Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., Sripadam, R., Mukherjee, S., Soonawalla, Z., Wadsley, J., Al-Mukhtar, A., Dickson, E., Graham, J., Jiao, L., Wasan, H. S., Tait, I. S., Prachalias, A., Ross, P., Valle, J. W., O'Reilly, D. A., Al-Sarireh, B., Gwynne, S., Ahmed, I., Connolly, K., Yim, K. L., Cunningham, D., Armstrong, T., Archer, C., Roberts, K., Ma, Y. T., Springfeld, C., Tjaden, C., Hackert, T., Büchler, M. W., Neoptolemos, J. P., and European Study Group for Pancreatic Cancer
- Subjects
Hepatology ,Gastroenterology - Abstract
BACKGROUND: Patients with borderline resectable pancreatic ductal adenocarcinoma have relatively low resection rates and poor survival despite the use of adjuvant chemotherapy. The aim of our study was to establish the feasibility and efficacy of three different types of short-course neoadjuvant therapy compared with immediate surgery. METHODS: ESPAC5 (formerly known as ESPAC-5f) was a multicentre, open label, randomised controlled trial done in 16 pancreatic centres in two countries (UK and Germany). Eligible patients were aged 18 years or older, with a WHO performance status of 0 or 1, biopsy proven pancreatic ductal adenocarcinoma in the pancreatic head, and were staged as having a borderline resectable tumour by contrast-enhanced CT criteria following central review. Participants were randomly assigned by means of minimisation to one of four groups: immediate surgery; neoadjuvant gemcitabine and capecitabine (gemcitabine 1000 mg/m(2) on days 1, 8, and 15, and oral capecitabine 830 mg/m(2) twice a day on days 1-21 of a 28-day cycle for two cycles); neoadjuvant FOLFIRINOX (oxaliplatin 85 mg/m(2), irinotecan 180 mg/m(2), folinic acid given according to local practice, and fluorouracil 400 mg/m(2) bolus injection on days 1 and 15 followed by 2400 mg/m(2) 46 h intravenous infusion given on days 1 and 15, repeated every 2 weeks for four cycles); or neoadjuvant capecitabine-based chemoradiation (total dose 50.4 Gy in 28 daily fractions over 5.5 weeks [1.8 Gy per fraction, Monday to Friday] with capecitabine 830 mg/m(2) twice daily [Monday to Friday] throughout radiotherapy). Patients underwent restaging contrast-enhanced CT at 4-6 weeks after neoadjuvant therapy and underwent surgical exploration if the tumour was still at least borderline resectable. All patients who had their tumour resected received adjuvant therapy at the oncologist's discretion. Primary endpoints were recruitment rate and resection rate. Analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN, 89500674, and is complete. FINDINGS: Between Sept 3, 2014, and Dec 20, 2018, from 478 patients screened, 90 were randomly assigned to a group (33 to immediate surgery, 20 to gemcitabine plus capecitabine, 20 to FOLFIRINOX, and 17 to capecitabine-based chemoradiation); four patients were excluded from the intention-to-treat analysis (one in the capecitabine-based chemoradiotherapy withdrew consent before starting therapy and three [two in the immediate surgery group and one in the gemcitabine plus capecitabine group] were found to be ineligible after randomisation). 44 (80%) of 55 patients completed neoadjuvant therapy. The recruitment rate was 25.92 patients per year from 16 sites; 21 (68%) of 31 patients in the immediate surgery and 30 (55%) of 55 patients in the combined neoadjuvant therapy groups underwent resection (p=0.33). R0 resection was achieved in three (14%) of 21 patients in the immediate surgery group and seven (23%) of 30 in the neoadjuvant therapy groups combined (p=0.49). Surgical complications were observed in 29 (43%) of 68 patients who underwent surgery; no patients died within 30 days. 46 (84%) of 55 patients receiving neoadjuvant therapy were available for restaging. Six (13%) of 46 had a partial response. Median follow-up time was 12.2 months (95% CI 12.0-12.4). 1-year overall survival was 39% (95% CI 24-61) for immediate surgery, 78% (60-100) for gemcitabine plus capecitabine, 84% (70-100) for FOLFIRINOX, and 60% (37-97) for capecitabine-based chemoradiotherapy (p=0.0028). 1-year disease-free survival from surgery was 33% (95% CI 19-58) for immediate surgery and 59% (46-74) for the combined neoadjuvant therapies (hazard ratio 0.53 [95% CI 0.28-0.98], p=0.016). Three patients reported local disease recurrence (two in the immediate surgery group and one in the FOLFIRINOX group). 78 (91%) patients were included in the safety set and assessed for toxicity events. 19 (24%) of 78 patients reported a grade 3 or worse adverse event (two [7%] of 28 patients in the immediate surgery group and 17 [34%] of 50 patients in the neoadjuvant therapy groups combined), the most common of which were neutropenia, infection, and hyperglycaemia. INTERPRETATION: Recruitment was challenging. There was no significant difference in resection rates between patients who underwent immediate surgery and those who underwent neoadjuvant therapy. Short-course (8 week) neoadjuvant therapy had a significant survival benefit compared with immediate surgery. Neoadjuvant chemotherapy with either gemcitabine plus capecitabine or FOLFIRINOX had the best survival compared with immediate surgery. These findings support the use of short-course neoadjuvant chemotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma. FUNDING: Cancer Research UK.
- Published
- 2023
47. The Impact of Ergonomic Interventions on the Whole Body Vibration of Mining Machinery Drivers in Sarcheshmeh Copper Complex
- Author
-
SAEED GHANEH, YASER SHAHRNAVARD, MASOUMEH KARAMI, and ZOHREH KARAMI
- Subjects
Whole body vibration ,mining machinery ,ergonomic interventions ,Environmental technology. Sanitary engineering ,TD1-1066 - Abstract
The existence of mechanical vibrations inside and around the industrial machinery and the constant exposure of the operators to these vibrations, increase the risk of musculoskeletal disorders in the operators and gradually affect their general health. The research is an attempt to investigate the effects of ergonomic interventions on the whole body vibration (WBV) of heavy machinery drivers in Sarcheshmeh Copper Complex in southern Iran. To evaluate the drivers’ exposure to WBV, a total number of 25 drivers, out of 45 drivers working in the complex, were selected. The vibration level was measured for each operator before and after the intervention using Bruel & Kjaer 4447 HAVS – Hand-Arm and Whole Body Vibration Meter. The measurements were conducted simultaneously in three axes (X, Y, and Z) in accordance with ISO 2631-1:1997. The obtained results were compared with the occupational exposure limits, recommended by the Iranian Ministry of Health and Medical Education (MoHME) of Iran, as a national standard. The data analysis was done by the independent t-test in SPSS software version 19. The obtained results revealed that prior to the intervention; the highest exposure to WBV was in the z-axis, which was the main axis of vibration entry into the drivers’ body. The results also showed that the equivalent acceleration of all vehicles exceeded the permissible limits (0.65 m/s2). The mean and maximum exposure levels were 0.66 and 0.56 m/s2 before the interventions and 0.88 and 0.63m/s2 after the interventions, which were significantly different (P
- Published
- 2018
48. Calculation of Dose Distribution in Irradiation Chamber of the SVHI-Co-60-T Portable Irradiation System Before and After Loading, Using MCNP4C Code and Comparison with the Results of the PMMA Dosimeters to Use for Wheat Irradiation
- Author
-
Navid Balkanian, Milaeil Yeganeh, Ayat Ghaneh, Mehdi Taghavi, and Abbas Modaber
- Subjects
portable irradiation system ,svhi-co-60-t ,pmma dosimeters ,mcnp4c code ,Nuclear and particle physics. Atomic energy. Radioactivity ,QC770-798 - Abstract
SVHI-Co-60-T irradiation system has been used as a portable one with Co-60 source for onion irradiation. To optimize and for the change of the system application, sufficient knowledge of the absorbed dose of the products is necessary. In this paper, the absorbed dose in the irradiation chamber is calculated for different points using MCNP4C code and then the results are compared with the measurements by the Red, Amber and Clear dosimeters of the Radiation Application Research School, along the central line of the chamber. The values obtained from dosimeters are in good agreement with the code results. The dose distribution in the irradiation chamber has been calculated on a plane with dimensions of 60cm×30cm. The minimum and maximum dose rates and the dose rate at the center of the same dose area of the isodose curve are 0.3kGy/hr, 2.6kGy/hr and 1.25kGy/hr, respectively. Also, the dose rate measured in the central area of the chamber using Red, Amber and Clear dosimeters is 1.37kGy/hr, 1.303kGy/hr and 1.302kGy/hr, respectively. Differences between the calculated dose using MCNP4C code and the measured dose emplaying three types of dosimeters are 8.7%, 3.8% and 3.8%, respectively. After loading, the spacers have been designed in front of new sources with MCNP4C code to have suitable dose with a uniform ratio to change its application from onion to wheat irradiation and also to compare with the measurements.
- Published
- 2014
49. Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study
- Author
-
Yip, V.S., Gomez, D., Tan, C.Y., Staettner, S., Terlizzo, M., Fenwick, S., Malik, H.Z., Ghaneh, P., and Poston, G.
- Published
- 2013
- Full Text
- View/download PDF
50. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)
- Author
-
Miao, Y, Lu, Z, Yeo, C, Vollmer, C, Fernandez-del Castillo, C, Ghaneh, P, Halloran, C, Kleeff, J, de Rooij, T, Werner, J, Falconi, M, Friess, H, Zeh, H, Izbicki, J, He, J, Laukkarinen, J, Dejong, C, Lillemoe, K, Conlon, K, Takaori, K, Gianotti, L, Besselink, M, Del Chiaro, M, Montorsi, M, Tanaka, M, Bockhorn, M, Adham, M, Olah, A, Salvia, R, Shrikhande, S, Hackert, T, Shimosegawa, T, Zureikat, A, Ceyhan, G, Peng, Y, Wang, G, Huang, X, Dervenis, C, Bassi, C, Neoptolemos, J, Buchler, M, Miao Y., Lu Z., Yeo C. J., Vollmer C. M., Fernandez-del Castillo C., Ghaneh P., Halloran C. M., Kleeff J., de Rooij T., Werner J., Falconi M., Friess H., Zeh H. J., Izbicki J. R., He J., Laukkarinen J., Dejong C. H., Lillemoe K. D., Conlon K., Takaori K., Gianotti L., Besselink M. G., Del Chiaro M., Montorsi M., Tanaka M., Bockhorn M., Adham M., Olah A., Salvia R., Shrikhande S. V., Hackert T., Shimosegawa T., Zureikat A. H., Ceyhan G. O., Peng Y., Wang G., Huang X., Dervenis C., Bassi C., Neoptolemos J. P., Buchler M. W., Miao, Y, Lu, Z, Yeo, C, Vollmer, C, Fernandez-del Castillo, C, Ghaneh, P, Halloran, C, Kleeff, J, de Rooij, T, Werner, J, Falconi, M, Friess, H, Zeh, H, Izbicki, J, He, J, Laukkarinen, J, Dejong, C, Lillemoe, K, Conlon, K, Takaori, K, Gianotti, L, Besselink, M, Del Chiaro, M, Montorsi, M, Tanaka, M, Bockhorn, M, Adham, M, Olah, A, Salvia, R, Shrikhande, S, Hackert, T, Shimosegawa, T, Zureikat, A, Ceyhan, G, Peng, Y, Wang, G, Huang, X, Dervenis, C, Bassi, C, Neoptolemos, J, Buchler, M, Miao Y., Lu Z., Yeo C. J., Vollmer C. M., Fernandez-del Castillo C., Ghaneh P., Halloran C. M., Kleeff J., de Rooij T., Werner J., Falconi M., Friess H., Zeh H. J., Izbicki J. R., He J., Laukkarinen J., Dejong C. H., Lillemoe K. D., Conlon K., Takaori K., Gianotti L., Besselink M. G., Del Chiaro M., Montorsi M., Tanaka M., Bockhorn M., Adham M., Olah A., Salvia R., Shrikhande S. V., Hackert T., Shimosegawa T., Zureikat A. H., Ceyhan G. O., Peng Y., Wang G., Huang X., Dervenis C., Bassi C., Neoptolemos J. P., and Buchler M. W.
- Abstract
Background: The aim was to evaluate the various operative techniques and outcomes used to manage the pancreatic transection plane (or stump) during a left (distal) pancreatectomy and to develop expert consensus guidelines. Methods: Evidence-based, clinically relevant questions were discussed and then were circulated among members of the International Study Group of Pancreatic Surgery. After agreement on the questions and statements, voting in a 9-point Likert scale was used to gauge the level of objective support for each. Results: Studies using the International Study Group of Pancreatic Surgery definition of postoperative pancreatic fistula including 16 randomized trials were reviewed to generate a series of statements set into 14 domains. There was strong consensus in the following statements: there was no difference in the postoperative pancreatic fistula rate after left pancreatectomy between the handsewn and stapler techniques; a stapling technique could not be used in all cases of left pancreatectomy; the use of an energy-based tissue sealant or a chemical sealant device or combinations of these did not impact the postoperative pancreatic fistula rate; there was no difference in the postoperative pancreatic fistula rate between the open, laparoscopic, or robotic approaches; and there are 1 or more clinically important, patient-related risk factors associated with the postoperative pancreatic fistula rate. There was weak or conditional agreement on the use of prophylactic somatostatin analogs, stents, stump closure, stump anastomosis, and the role of abdominal drains. Conclusion: Areas of strong consensus suggests a change in clinical practice and priority setting. Eight domains with lower agreement will require novel approaches and large multicenter studies to determine future key areas of practice.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.